In recent study, 23 percent of NHANES primary prevention cohort currently using lipid-lowering therapies versus 47 percent eligible under U.S. guidelines.

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subject in the YOSEMITE Phase 3 clinical trial of zodasiran, the company’s investigational RNA interference ...

Do you have high cholesterol? You're not alone — millions of adults in the United States face this common but serious issue. High cholesterol increases the risk of heart disease, ...

Heart disease is often seen as a problem that only affects older adults, but more and more young people are being diagnosed ...

The placebo-controlled study is aimed at assessing the safety and efficacy of zodasiran in adults and adolescents with HoFH.

What to Know About Managing Familial Hypercholesterolemia — A multipronged approach is needed for these patients to achieve adequate cholesterol lowering ...

Eli Lilly & Co. has divulged relaxin receptor 1 (RXFP1; LGR7) agonists reported to be useful for the treatment of diabetes, stroke, atherosclerosis, pulmonary hypertension, chronic obstructive ...

The firm is hoping to show that the RNAi drug can treat HoFH by reducing production of ANGPTL3, which regulates lipid and lipoprotein metabolism.

Margie Junker, an expert in cardiovascular nutrition, has shared seven foods she eats for a healthy heart, as well as some ...

Cholesterol is a type of fat found in your blood, and while your body needs it to create healthy cells, having high cholesterol levels can increase your risk of heart disease ...

Q: I used to be a serious exerciser, but now that I am in my late 60s, I find it harder and harder to stay on track. Got any words ...

A 79p "superfood" could be instrumental in reducing cholesterol, according to a weight loss expert. This wallet-friendly ...